FTC sues significant pharmacy reward managers in excess of insulin costs The agency brought action against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list price of life-preserving insulin medicine. Exactly where are many of the nurses? Hospitals, advocates disagree on crisis https://elliottvmduk.blogolenta.com/27556915/indicators-on-healthcare-news-you-should-know